Dehydroepiandrosterone (DHEA) Feeding Protects Liver Steatosis in Obese Breast Cancer Rat Model

Dehydroepiandrosterone (DHEA) Feeding Protects Liver Steatosis in Obese Breast Cancer Rat Model

Obesity is a major health problem in the US and globally. Obesity is associated with the risk of cardiovascular disease, type 2 diabetes, cancers, hyperlipidemia, and liver steatosis development. Dehydroepiandrosterone (DHEA) is a dietary supplement used as an anti-obesity supplement. Previously, we...

Full description

Bibliographic Details
Main Authors: Reza Hakkak, Andrea Bell, Soheila Korourian
Format: Article
Language:English
Published: Österreichische Apotheker-Verlagsgesellschaft m. b. H. 2017-03-01
Series:Scientia Pharmaceutica
Subjects:
DHEA
obesity
liver steatosis
weight loss
Online Access:http://www.mdpi.com/2218-0532/85/1/13

Internet

http://www.mdpi.com/2218-0532/85/1/13

Similar Items